Every 8-K that Nukkleus Inc. Warrants (NUKKW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow NUKKW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NUKKW filings page.
T3 Defense Inc. appointed Roy Cohen as its new Chief Financial Officer, effective June 1, 2026, to serve at the Board’s discretion until a successor is appointed and qualified. Cohen has more than 25 years of financial leadership experience across global public and private companies, including senior roles at NASDAQ-listed businesses and responsibility for consolidated US GAAP reporting and Sarbanes-Oxley compliance.
He will receive monthly compensation of NIS 55,000 through September 2026, rising to NIS 65,000 per month thereafter. The company states he has no relevant related-party transactions, no recent bankruptcy affiliations, and no familial ties to its directors or executive officers.
T3 Defense Inc. entered into a Note Exchange Agreement with its CEO, Menachem Shalom, on April 27, 2026. The original notes assigned to him, with outstanding principal and accrued interest totaling $2,138,962, were cancelled in exchange for 4,174,399 restricted shares of common stock at an exchange price of $0.5124 per share, equal to the last consolidated bid price on Nasdaq.
The company treated this as an unregistered equity issuance relying on Section 4(a)(2) and/or Rule 506 of Regulation D. The Board also resolved that Mr. Shalom may convert his remaining notes at $0.5124 per share and reduced the exercise price of his “Star Warrant” from $1.50 to $0.5124 per share for 7,175,662 common shares.
T3 Defense Inc., through its majority-owned Tel Aviv–listed affiliate Water IO Ltd., announced a non-binding letter of intent to lend $10,000,000 to Israeli defense company Meteor Aerospace Ltd.
If the loan is completed under definitive agreements, Meteor would issue Water IO 51% of its outstanding shares on a post-investment basis. Closing depends on Water IO completing a public offering of convertible notes on the Tel Aviv Stock Exchange, satisfactory due diligence, definitive documentation, and required regulatory approvals.
The company states that, if the transaction is consummated, there will be no dilutive effect to T3 Defense Inc. Meteor develops unmanned systems and precision-guided weapons, with four of its five product lines described as having reached commercial maturity.
T3 Defense Inc. reported unaudited preliminary key metrics for Q1 2026, its first full quarter operating as a defense-focused holding company. Operating subsidiaries in areas such as anti-missile systems, drone navigation, counter-drone solutions, defense engineering, and tactical power and mobility systems generated $4.2 million in revenue, providing an initial operating baseline.
The company reaffirmed full-year 2026 consolidated revenue guidance of $26 million, reflecting an expanding contract base and growing engagement with defense agencies and prime contractors in the U.S. and Israel. T3 Defense reported a consolidated backlog of $12.1 million, which helps support near-term revenue visibility, and noted it has received $12.0 million in requests for proposals (RFPs) in recent months, tied to heightened geopolitical tensions and rising global defense spending.
T3 Defense Inc., through its majority-owned Israeli affiliate Water IO Ltd., completed the sale of its AI defense subsidiary Zorro Net Ltd. to BiomX Inc. on April 10, 2026. Zorronet provides AI-powered computer vision and autonomous surveillance systems deployed at Israeli defense and critical infrastructure sites.
As consideration, BiomX issued 1,300,000 shares of its common stock to Water IO and a $1,250,000 non-convertible promissory note maturing three months after issuance. BiomX also assumed obligations including a performance-based earnout for fiscal 2026 and commitments to retain key Zorronet personnel for three years.
Following the share issuance, Water IO holds 1,300,000 BiomX shares, representing about 16.57% of BiomX’s common stock. T3 Defense, through its wholly owned subsidiary Star 26 Capital Inc., owns roughly 67% of Water IO and may be deemed to beneficially own the BiomX stake indirectly.
T3 Defense Inc., through its affiliated SPAC sponsor, reported that on March 31, 2026 SC II Acquisition Corp. entered into a non-binding letter of intent with a payments technology company for a potential business combination.
The LOI outlines a possible deal in which SC II Acquisition Corp. would acquire 100% of the target’s outstanding equity and equity equivalents, but it is expressly preliminary and does not obligate either party to complete a transaction. Only limited provisions such as exclusivity, confidentiality, waiver of claims against the SPAC’s trust account, and governing law are binding, and the companies highlight numerous risks and uncertainties that could prevent any definitive agreement or closing.
T3 Defense Inc. entered into a Cancellation Agreement on March 31, 2026 that eliminates a $16,000,000 obligation owed to its wholly owned subsidiary, Star 26 Capital, Inc. The cancelled amount covered principal, accrued interest and all related amounts.
The company states this cancellation is effective immediately at no cost, no dilution, and with no offsetting obligation to T3 Defense or its shareholders. T3 Defense keeps full 100% ownership of Star 26 and all of its assets, and the underlying acquisition agreement remains in full force.
T3 Defense Inc. filed an amended current report to add detailed financial information for its acquisition of 51% of I.T.S. Industrial Techno-Logic Solutions Ltd. (ITS). The filing includes ITS’s audited 2023–2024 financial statements and pro forma combined statements showing how T3 Defense and ITS would look on a combined basis.
ITS generated $8.9 million in 2024 revenue but recorded a net loss and a shareholders’ deficit, and its auditors highlighted substantial doubt about ITS’s ability to continue as a going concern. The pro forma statements also show significant goodwill recorded from the ITS acquisition and illustrate the combined group’s leverage and operating losses.
T3 Defense Inc. filed a Form 8-K to share that its indirectly wholly owned subsidiary, Tiltan Software Engineering Ltd., was featured in a media article and interview with its acting CEO. The article, furnished as Exhibit 99.1, highlights Tiltan’s more than 30-year role in the Israeli defense sector, providing high-precision training and synthetic data services.
Tiltan focuses on “digital twins and mapping,” using advanced geospatial systems to rapidly generate complex, physics-based environments for defense training, debriefing, and planning. The piece notes that Tiltan was acquired by T3 Defense last year and is preparing for international expansion, aiming to bring its technology to new markets in Asia and the United States.
T3 Defense Inc. reported that it has been named as a defendant in a civil action in the Supreme Court of the State of New York. The complaint, dated February 24, 2026, was filed by Kingswood Capital Partners, LLC against Star 26 Capital, Inc., Nukkleus, Inc. and the Company.
The complaint alleges that a success fee is due in connection with an earned investment banking success fee arising from a transaction. T3 Defense states that it denies all allegations and intends to vigorously defend the action, which it believes is without merit.
T3 Defense Inc. filed a current report describing a press release that highlights rising global demand for integrated air and missile defense and counter‑UAS capabilities. The company links this increased interest to the ongoing Iran conflict and broader geopolitical tensions that are driving urgent procurement and modernization cycles among allied defense forces.
The release explains that T3 Defense’s U.S. and Israeli portfolio businesses already have systems deployed on current battlefields, helping defend against ballistic and cruise missile salvos, one‑way attack drones, and other unmanned threats. Management reiterates a strategy focused on acquiring and scaling specialized defense companies across air defense, counter‑UAS, resilient navigation, and defense engineering.
T3 Defense emphasizes that its portfolio is oriented toward defensive and aerospace applications designed to reduce vulnerability to aerial threats and protect critical infrastructure and civilian populations. The company also underscores its commitment to employee safety and support for partners focused on de‑escalation, humanitarian efforts, and long‑term regional stability, while noting customary forward‑looking statement risks tied to defense funding, contracts, supply chains, and integration of acquisitions.
T3 Defense Inc. entered into a private placement for up to $20 million with an accredited investor, structured as 400 units at $50,000 each. An initial closing for 200 units will provide $10 million, with a second $10 million tranche contingent on shareholder approval, an effective resale registration statement, a minimum $1.00 share price and specified Nasdaq trading-value thresholds.
Each unit includes one Series B Convertible Preferred share with a $50,000 stated value, initially convertible at $2.13 per common share, and 1.5 common stock warrants initially exercisable at $0.0125 per share, both subject to anti-dilution adjustments and a 9.9% ownership cap. The preferred carries 10,000 votes per share, senior liquidation preference and potential 105% redemption if shareholder approval is not obtained after one year. A registration rights agreement imposes filing and effectiveness deadlines backed by 1.5% liquidated damages. The company will pay a 3.5% cash fee and 7.5% warrant coverage to its placement agent. Separately, director Aviya Volodarsky resigned from the board for personal reasons.
T3 Defense Inc. approved a new Consulting Agreement with Billio Ltd. to provide the services of Menachem Shalom as principal executive officer and continue his role as chief executive officer. The agreement replaces prior consulting and management arrangements tied to entities associated with Mr. Shalom.
The Compensation Committee and Board granted Mr. Shalom a $250,000 cash bonus for past services and set ongoing pay at a $60,000 monthly base salary plus target cash bonuses equal to 50% of base salary, subject to performance goals. He may also receive additional milestone-based bonuses determined by the Board.
Under the agreement, Mr. Shalom is to receive 250,000 shares of common stock each quarter, subject to availability under approved incentive plans that require shareholder approval under Nasdaq rules, with any shortfall accruing. He is eligible for a $175,000 relocation grant if he moves to the United States with his family, standard executive benefits, and 30 business days of annual vacation.
If terminated without cause, Mr. Shalom is entitled to six months of base compensation, while resignation entitles him to 12 months of compensation; termination for cause limits him to accrued compensation only. The agreement includes customary non-competition, non-solicitation, and confidentiality provisions.
T3 Defense Inc. completed the acquisition of 51% of I.T.S. Industrial Tecno-logic Solutions Ltd. (ITS), an Israeli engineering and manufacturing company, through its wholly owned subsidiary Star Twenty Six Ltd. The stake was obtained in exchange for loans totaling NIS 10,000,000 (approximately $3.24 million) previously extended to ITS.
The company holds a three-year exclusive option to buy the remaining 49% of ITS for 25 million NIS, 30 million NIS, or 35 million NIS if exercised in the first, second, or third year, respectively. ITS and its subsidiary Positech add advanced electro-mechanical production and precision motion control capabilities, and with ITS included, T3 Defense now estimates annual revenue in the range of $24–$26 million.
T3 Defense Inc. furnished an investor presentation under Regulation FD, updating investors on its strategy, portfolio and recent acquisitions. As of February 9, 2026, the company reported 25.3 million shares outstanding, a $2.39 share price, a $60.5 million market capitalization and 1.7 million average three-month trading volume.
The presentation describes a defense-focused M&A platform targeting small and mid-sized companies and notes that 2025 was “transformational,” with three acquisitions and multiple joint ventures and distribution agreements completed. The current portfolio is expected to generate $20–22 million of revenue in 2026, with exposure to drones, robotics, AI, counter‑drone systems and tactical energy.
Management highlights the Star26 acquisition in January 2026, expanding into unmanned systems and motion control, and notes that B. Rimon recently secured approximately $4.1 million in new multi‑year contracts related to the Iron Dome and other active defense programs. The presentation also cites industry data pointing to growth in military UAV markets and increased global defense spending.
T3 Defense Inc., formerly Nukkleus Inc., has changed its corporate name and Nasdaq ticker to better reflect its defense-focused strategy. Effective February 9, 2026, the company adopted the name T3 Defense Inc. and now trades on Nasdaq under the ticker DFNS, with no change to its CUSIP and no action required from shareholders.
The company describes itself as a federated holding company acquiring and operating mission-critical defense businesses embedded in long-cycle national security programs. Its subsidiaries support areas such as air defense, homeland security, AI for defense, and Israel’s national missile and air-defense architecture, including Iron Dome, under multi-year contracts that provide revenue visibility.
Nukkleus Inc. filed a current report to note that on February 3, 2026 it issued a press release, which is attached as Exhibit 99.1. The company emphasizes that this press release and the related Item 8.01 information are being furnished, not filed, so they are not subject to certain Exchange Act liabilities or automatically incorporated into other SEC filings.
Nukkleus Inc. furnished a press release that provides updates on its recent acquisitions and outlines its growth strategy for 2026. The company frames these plans using forward-looking statements that depend on a number of business and financial factors.
The disclosure highlights risks around integrating Star 26 and realizing expected benefits from that acquisition, the sufficiency of working capital to carry out business plans, and a going concern qualification in its financial statements. It also points to uncertainties in penetrating new markets, retaining key personnel, and gaining market acceptance for its products and services.
Nukkleus further notes exposure to changes in the defense industry and government spending, geopolitical risks, competition, and access to capital markets, all of which could cause actual performance to differ materially from its current expectations.
Nukkleus Inc. filed an 8-K reporting the execution of a Common Stock Purchase Agreement and a Registration Rights Agreement with Esousa Group Holdings, LLC, both dated September 19, 2025. The filing lists a related press release dated September 19, 2025 and includes a signed cover page by Menachem Shalom, Chief Executive Officer. The listed exhibits indicate a transaction and accompanying registration mechanics were agreed the same day, and the company provided interactive XBRL cover-page data.
The filing text is brief and focuses on the existence and dates of the agreements and press release; it does not disclose deal economics, share counts, consideration, or other financial terms, so material financial impacts are not specified within this document.
Nukkleus Inc. filed an 8-K describing material terms and exhibits related to publicly traded warrants (ticker NUKKW) and related securities. The filing states each warrant is exercisable for one share of common stock at an exercise price of $92.00 per share and lists conditions that must be satisfied for certain exercise or exchange rights, including that the market price exceed $6.76 during a Measurement Period, the company be compliant with listing requirements, the warrant shares be registered for resale, and the company not be in default under the common warrant. The filing attaches key documents: a Certificate of Designation for Series A preferred, forms of warrants and pre-funded warrants, a Securities Purchase Agreement and Registration Rights Agreement dated September 4, 2025, a Placement Agent Agency Agreement, and a press release dated September 5, 2025. The filing is signed by CEO Menachem Shalom.
Nukkleus Inc. reported that Nasdaq has notified the company it no longer meets the Nasdaq Global Market requirement to maintain a minimum market value of listed securities of $50,000,000 over 30 consecutive business days. This places its current Global Market listing at risk.
Under Nasdaq rules, Nukkleus has 180 calendar days, until February 24, 2026, to regain compliance by having its market value reach at least $50,000,000 for a minimum of ten consecutive business days, or potentially up to 20 days at Nasdaq’s discretion. During this period, its common stock and warrants will continue trading on the Nasdaq Global Market under the symbols “NUKK” and “NUKKW” while the company monitors its market value and evaluates options, including a possible transfer to the Nasdaq Capital Market or an appeal if a delisting determination is issued.
Nukkleus Inc. disclosed a set of closing conditions tied to a change of control involving Tiltan. The filing lists required regulatory approvals including notification to the Israeli Defense Export Controls Agency, delivery of PCAOB-compliant audited financial statements for Tiltan for fiscal years 2023 and 2024 and quarterly financial statements for 2025 (with the company reimbursing Tiltan for audit costs), and a dividend distribution to the shareholder immediately prior to closing. The document also requires the accuracy of representations and warranties in all material respects, absence of any material adverse effect on Tiltan, and execution of customary ancillary agreements. The filing is dated September 1, 2025 (signature dated September 2, 2025).
Nukkleus Inc. filed an 8-K reporting the issuance of warrants and a joint venture agreement dated August 28, 2025. The filing identifies two securities: Common Stock (ticker NUKK) and Warrants exercisable for one share at an exercise price of $92.00 (ticker NUKKW), both listed on The Nasdaq Stock Market. Exhibits include two warrants issued as of August 28, 2025 and a Joint Venture Agreement dated August 28, 2025 among Nukkleus Inc., Nukk Picolo Ltd. and Mandragola Ltd. The filing is signed by CEO Menachem Shalom on August 29, 2025.
Nukkleus Inc. entered into an Exclusive Distribution Agreement with Blade Ranger Ltd., an Israeli public company that develops drone payloads for the solar energy market and for defense and homeland security forces. Under the agreement, Blade Ranger granted Nukkleus exclusive U.S. distribution rights for defense and homeland security customers for a proprietary drone payload.
Nukkleus will pay $100,000 for these exclusive U.S. rights, with the first payment due by the end of November 2025 and three equal quarterly payments thereafter. The company committed to purchase 5 units in Year 1, 10 units in Year 2, and 15 units in Year 3. If these targets are met, the agreement extends for five additional years with a 20‑unit annual purchase commitment, and if Nukkleus achieves 125% of revenue targets in any year, it earns an 8% credit on annual purchases.
Nukkleus also plans to form a new Delaware subsidiary, Nukkleus Defense Technologies, Inc., to commercialize third‑party defense‑related technologies, including Blade Ranger’s products, and to explore proprietary solutions for defense and aerospace markets.
Item 8.01 – Subsidiary enters administration; DRFQ divested. On 29-Jul-25, UK subsidiary Match Financial Ltd. was placed into administration under the Insolvency Act 1986. Court-appointed administrators immediately executed a pre-pack sale of Match Financial’s entire holding in Digital RFQ Ltd. to newly formed Match Financial Holdings Ltd., owned by director Jamal Khurshid, for nominal consideration of £102,000.
The sale removes DRFQ from Nukkleus’s consolidation. Management states Match Financial contributed “negligible” revenue and assets, so it does not expect a material adverse impact on the group’s financial position or operations.
Strategic update – Star 26 Capital acquisition. The Company continues to seek shareholder approval for the December 2024 Securities Purchase Agreement and Call Option to acquire a controlling 51 % stake in Star 26 Capital Inc., which owns Israeli generator supplier Rimon and would advance Nukkleus’s defence-sector strategy.